Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver
Ichiro Onoyama, Atsushi Suzuki, Akinobu Matsumoto, Kengo Tomita, Hideki Katagiri, Yuichi Oike, Keiko Nakayama, Keiichi I. Nakayama
Ichiro Onoyama, Atsushi Suzuki, Akinobu Matsumoto, Kengo Tomita, Hideki Katagiri, Yuichi Oike, Keiko Nakayama, Keiichi I. Nakayama
View: Text | PDF
Research Article Hepatology

Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver

  • Text
  • PDF
Abstract

E3 ubiquitin ligase complexes of the SCF type consist of ring-box 1 (Rbx1), cullin 1 (Cul1), S-phase kinase-associated protein 1 (Skp1), and a member of the F-box family of proteins. The identity of the F-box protein determines the substrate specificity of the complex. The F-box family member F-box– and WD repeat domain–containing 7 (Fbxw7; also known as Fbw7, SEL-10, hCdc4, and hAgo) targets for degradation proteins with wide-ranging functions, and uncovering its in vivo role has been difficult, because Fbxw7–/– embryos die in utero. Using two different Cre-loxP systems (Mx1-Cre and Alb-Cre), we generated mice with liver-specific null mutations of Fbxw7. Hepatic ablation of Fbxw7 resulted in hepatomegaly and steatohepatitis, with massive deposition of triglyceride, a phenotype similar to that observed in humans with nonalcoholic steatohepatitis. Both cell proliferation and the abundance of Fbxw7 substrates were increased in the Fbxw7-deficient liver. Long-term Fbxw7 deficiency resulted in marked proliferation of the biliary system and the development of hamartomas. Fbxw7 deficiency also skewed the differentiation of liver stem cells toward the cholangiocyte lineage rather than the hepatocyte lineage in vitro. This bias was corrected by additional loss of the Notch cofactor RBP-J, suggesting that Notch accumulation triggered the abnormal proliferation of the biliary system. Together, our results suggest that Fbxw7 plays key roles, regulating lipogenesis and cell proliferation and differentiation in the liver.

Authors

Ichiro Onoyama, Atsushi Suzuki, Akinobu Matsumoto, Kengo Tomita, Hideki Katagiri, Yuichi Oike, Keiko Nakayama, Keiichi I. Nakayama

×

Figure 5

Hamartoma development as a result of long-term ablation of Fbxw7 in the liver.

Options: View larger image (or click on image) Download as PowerPoint
Hamartoma development as a result of long-term ablation of Fbxw7 in the ...
(A) Gross appearance of the livers of Mx1-Cre/Fbxw7+/F and Mx1-Cre/Fbxw7F/F mice at 50 weeks after the final injection of pIpC, beginning at 8 weeks of age. Scale bar: 10 mm. (B) PCR analysis of genomic DNA from the dilated bile ducts excised from hamartomas in the livers of 2 Mx1-Cre/Fbxw7F/F mice. Genomic DNA from control mice was also analyzed. (C–F) H&E staining of liver sections from a Mx1-Cre/Fbxw7+/F (+/Δ) mouse (C) and from a Mx1-Cre/Fbxw7F/F (Δ/Δ) mouse (D–F) that developed hamartoma after Fbxw7 deletion as in A. (G and H) H&E staining of liver sections from Fbxw7F/F (F/F) and Alb-Cre/Fbxw7F/F (Δ/Δ) mice, respectively, at 12 weeks of age. Arrowheads indicate malformation of the ductal plate. Scale bar: 50 μm (F); 100 μm (E, G, and H); 200 μm (C and D). (I and J) Immunofluorescence staining for CK19 in the livers of Mx1-Cre/Fbxw7+/F (+/Δ) and Mx1-Cre/Fbxw7F/F (Δ/Δ) mice at 50 weeks after the final injection of pIpC, beginning at 8 weeks of age. The dashed line indicates the outer boundary of portal vein. PV, portal vein; BD, bile duct. Scale bar: 25 μm. (K and L) RT and real-time PCR analysis of Alb and CK19 mRNAs, respectively, in the livers of Mx1-Cre/Fbxw7+/F (control) and Mx1-Cre/Fbxw7F/F mice at 1, 2, or 50 weeks after deletion of Fbxw7 as in A. Normalized data are expressed relative to the corresponding value for control mice. Data are mean ± SD from 3 independent experiments. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts